Additional file 1: Table S1. of Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation

Primers used to detect and quantify BB-12® and LGG®. Table S2. Strains used for evaluation of primer specificity. Table S3. OTUs with differential abundance comparing baseline samples. Table S4. OTUs with differential abundance comparing samples with BB-12® growth to placebo. Table S5. OTUs with differential abundance comparing samples with LGG® growth to placebo. Figure S1. Gut microbiota changes over the course of the 6 months intervention. Figure S2. Gut microbiota at baseline does not differ between probiotics and placebo groups. Figure S3. Evaluation of primer specificity for LGG® and BB-12® primers. Figure S4. Gut microbial alpha diversity measures are not affected by active growth of probiotics. (PDF 532 kb)